Reactive astrocytes are reported to use NOX signaling to stimulate Lcn2 expression and secretion, and blocking astrocytic NHE1 activity promotes the reduction of Lcn2-mediated neurotoxicity after stroke [33]. This evidence concerns the gene LCN2 and stroke disorder.